CD163 and metabolic dysfunction-associated steatotic liver disease: Areas under the Receiver Operating Characteristics curve with 95% Confidence Intervals for the prediction of combined fibrosis ≥2, NAFLD activity score ≥4 and steatohepatitis by sCD163, sMR, AST and transient elastography in the Italian and Swedish cohorts.